RxDoctor Payments Data

Kirk Watkins, MD

Sleep Medicine · St George, UTNPI 1326220559

Payments from drug & device makers

What this record shows

This record is dominated by speaking fees: $184,604 of the $247,674 with a category attached, or 74.5%. Jazz Pharmaceuticals Inc. accounts for 90.8% of it on its own, with 5 other manufacturers making up the rest. Among sleep medicine clinicians in UT with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$247,674in general payments, 2019–2025

Across 254 payments — averaging $975.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Jazz Pharmaceuticals Inc.$225K
  • Harmony Biosciences LLC$21K
  • ZOLL Respicardia, Inc.$2K
  • Eisai Inc.$125
  • Resmed Corp$55
  • Inspire Medical Systems, Inc.$37

What the payments were for

  • Consulting fees$16,8737%
  • Speaking & faculty fees$184,60475%
  • Travel & lodging$39,69016%
  • Food & beverage$6,4373%
  • Education$700%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$247,674 in reported general payments places this provider in the 95th percentile of 20 sleep medicine providers in Utah.

See all sleep medicine providers in Utah

Medicare billing

Part B allowed, 2024
$73,915
Medicare patients
439
Services billed
663

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
XywavSodium,calcium,mag,pot Oxybate62$995,966
WakixPitolisant Hcl66$847,180
Sodium Oxybate45$676,768
SunosiSolriamfetol Hcl26$22,483
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine88$3,434
Doxepin Hcl70$2,363
Armodafinil30$2,233
Modafinil34$1,971
Triazolam26$1,963
Gabapentin97$1,836
Baclofen54$1,193
Dextroamphetamine Sulfate12$1,030
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen31$792
Methylphenidate Hcl16$779
Zolpidem Tartrate99$771

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Harmony Biosciences LLCWakix$20,598$847,18066 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 20 sleep medicine providers in Utah.

Other sleep medicine in St George

See the full list for Utah

Where these figures come from

Is this you, or does something look wrong? →